Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma

Clinical trial NCT00390338 · COMPLETED

Trial details

NCT number: NCT00390338
Sponsor: Pawel Kalinski
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Melanoma (Skin)

Start date: 2006-10-01
Primary completion: 2012-05-01
Enrollment: 22

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.